<DOC>
	<DOCNO>NCT00637143</DOCNO>
	<brief_summary>The purpose study compare renal transplant recipient cyclosporine maintenance therapy vs. convert tacrolimus-based immunosuppression respect renal outcome .</brief_summary>
	<brief_title>Tacrolimus Secondary Intervention v . Continuation Cyclosporine Renal Transplant Patients With Chronic Renal Allograft Failure ( CRAF )</brief_title>
	<detailed_description>The objective study compare incidence , progression severity chronic renal allograft failure at-risk patient convert cyclosporine tacrolimus-based immunosuppression patient remain cyclosporine .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patient least 3 month posttransplant cadaveric living donor kidney Patient cyclosporinebased immunosuppression regimen since transplant Patient one follow risk factor chronic renal allograft failure baseline biopsy : Serum creatinine : Male : &gt; =2.0mg/dL ( 176.8 umol/L ) ; Female : &gt; = 1.7mg/dL ( 150.28 umol/L ) 3 month later posttransplant Serum creatinine &gt; 30 % increase postdischarge nadir Patient renal biopsy &gt; 3 month transplant within 6 month prior enrollment Patient legal guardian sign dated IRB approve informed consent document Female patient negative pregnancy test agree practice effective birth control receive mycophenolate mofetil ( MMF ) Patient dialysis dependent recurrence primary de novo renal disease Patient estimate creatinine clearance &lt; 25mL/min Patient change maintenance immunosuppressant therapy ( e.g. , azathioprine MMF ) within 3 month randomization Baseline biopsy show acute rejection Grade &gt; =IIB use Banff 95 criterion &gt; = Grade IIA use Banff 97 criterion Patient require antilymphocyte therapy treat rejection baseline postbaseline biopsy Patient receive investigational immunosuppressant within 3 month , know hypersensitivity tacrolimus , excipients drug Patient know carrier HIV virus</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Renal transplant</keyword>
	<keyword>Cyclosporine</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Intervention</keyword>
	<keyword>Interstitial Fibrosis Tubular Atrophy</keyword>
	<keyword>Chronic Renal Allograft Failure</keyword>
</DOC>